Key Points Researchers identified common neuroimmune signatures shared by rapid-acting antidepressants, including ketamine and psychedelics. The study suggests these therapies…
Key Points Researchers identified common neuroimmune signatures shared by rapid-acting antidepressants, including ketamine and psychedelics. The study suggests these therapies…